JW (Cayman) Therapeutics Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Min Liu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 2yrs |
Recent management updates
Recent updates
Market Cool On JW (Cayman) Therapeutics Co. Ltd's (HKG:2126) Revenues Pushing Shares 37% Lower
Apr 08
Market Might Still Lack Some Conviction On JW (Cayman) Therapeutics Co. Ltd (HKG:2126) Even After 37% Share Price Boost
Feb 12Take Care Before Jumping Onto JW (Cayman) Therapeutics Co. Ltd (HKG:2126) Even Though It's 26% Cheaper
Nov 12JW (Cayman) Therapeutics Co. Ltd (HKG:2126) Screens Well But There Might Be A Catch
Sep 25A Piece Of The Puzzle Missing From JW (Cayman) Therapeutics Co. Ltd's (HKG:2126) 34% Share Price Climb
May 10Calculating The Intrinsic Value Of JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
May 03JW (Cayman) Therapeutics Co. Ltd (HKG:2126): When Will It Breakeven?
Feb 03CEO
Min Liu (51 yo)
less than a year
Tenure
Mr. Min Liu has been Chief Executive Officer and Executive Director of JW (Cayman) Therapeutics Co. Ltd. since July 31, 2024 and serves as its Executive Chairman since March 13, 2025. He serves as the Chie...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Director | less than a year | CN¥20.98m | 5.44% HK$ 34.8m | |
| CEO & Executive Chairman | less than a year | no data | no data | |
| Independent Non-Executive Director | 2.2yrs | CN¥276.00k | no data | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 4.6yrs | CN¥224.00k | no data | |
| Non-Executive Director | 4.9yrs | CN¥331.00k | 1.42% HK$ 9.1m | |
| Non-Executive Director | 1.8yrs | no data | no data | |
| Non-Executive Director | 5yrs | no data | no data |
2.0yrs
Average Tenure
56.5yo
Average Age
Experienced Board: 2126's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/02 03:15 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
JW (Cayman) Therapeutics Co. Ltd is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jin Zhang | China International Capital Corporation Limited |
| Ziyu He | China International Capital Corporation Limited |
| Tony Ren | CLSA |